These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 28396158)

  • 21. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis.
    Fukuoka K; Nakao K; Morimoto H; Nakao A; Takatori Y; Arimoto K; Taki M; Wada J; Makino H
    Nephrology (Carlton); 2008 Jun; 13(4):278-83. PubMed ID: 18476915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes.
    Matsumoto H; Murase-Mishiba Y; Yamamoto N; Sugitatsu-Nakatsukasa S; Shibasaki S; Sano H; Terasaki J; Imagawa A; Hanafusa T
    Intern Med; 2012; 51(11):1315-21. PubMed ID: 22687835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum glycated albumin predicts the progression of carotid arterial atherosclerosis.
    Song SO; Kim KJ; Lee BW; Kang ES; Cha BS; Lee HC
    Atherosclerosis; 2012 Dec; 225(2):450-5. PubMed ID: 23040867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease.
    Shen Y; Dai D; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J
    Cardiovasc Diabetol; 2020 Dec; 19(1):211. PubMed ID: 33302958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline glycated albumin level and risk of type 2 diabetes mellitus in Healthy individuals: a retrospective longitudinal observation in Korea.
    Shin KS; Park MS; Lee MY; Cho EH; Woo HY; Park H; Kwon MJ
    Scand J Clin Lab Invest; 2024 May; 84(3):168-173. PubMed ID: 38634263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of body mass index with glycated albumin and glycated albumin/glycated hemoglobin A
    He X; Mo Y; Ma X; Ying L; Zhu W; Wang Y; Bao Y; Zhou J
    Clin Chim Acta; 2018 Sep; 484():117-121. PubMed ID: 29802831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes - A prospective cohort study.
    Dai D; Shen Y; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J
    J Diabetes Complications; 2021 Sep; 35(9):107971. PubMed ID: 34187717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
    Ahn KH; Kim SS; Kim WJ; Kim JH; Nam YJ; Park SB; Jeon YK; Kim BH; Kim IJ; Kim YK
    Korean J Intern Med; 2017 Sep; 32(5):875-882. PubMed ID: 28560862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.
    Hoshino J; Hamano T; Abe M; Hasegawa T; Wada A; Ubara Y; Takaichi K; Inaba M; Nakai S; Masakane I;
    Nephrol Dial Transplant; 2018 Jul; 33(7):1150-1158. PubMed ID: 29528439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion.
    Shen Y; Lu L; Ding FH; Sun Z; Zhang RY; Zhang Q; Yang ZK; Hu J; Chen QJ; Shen WF
    Cardiovasc Diabetol; 2013 Nov; 12():165. PubMed ID: 24209601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of glycated albumin to HbA1c ratio with diabetic retinopathy but not diabetic nephropathy in patients with type 2 diabetes.
    Umayahara Y; Fujita Y; Watanabe H; Kasai N; Fujiki N; Hatazaki M; Koga M
    Clin Biochem; 2017 Apr; 50(6):270-273. PubMed ID: 27923630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of elevated serum glycated albumin levels on contrast-induced acute kidney injury in diabetic patients with moderate to severe renal insufficiency undergoing coronary angiography.
    Ding FH; Lu L; Zhang RY; Zhu TQ; Pu LJ; Zhang Q; Chen QJ; Hu J; Yang ZK; Shen WF
    Int J Cardiol; 2013 Jul; 167(2):369-73. PubMed ID: 22244477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease.
    Okada T; Nakao T; Matsumoto H; Shino T; Nagaoka Y; Tomaru R; Wada T
    Intern Med; 2007; 46(12):807-14. PubMed ID: 17575371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus.
    Jeon WS; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
    Diabetes Res Clin Pract; 2016 Jun; 116():46-53. PubMed ID: 27321316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
    Freedman BI; Andries L; Shihabi ZK; Rocco MV; Byers JR; Cardona CY; Pickard MA; Henderson DL; Sadler MV; Courchene LM; Jordan JR; Balderston SS; Graham AD; Mauck VL; Russell GB; Bleyer AJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1635-43. PubMed ID: 21597024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.
    Isshiki K; Nishio T; Isono M; Makiishi T; Shikano T; Tomita K; Nishio T; Kanasaki M; Maegawa H; Uzu T;
    Ther Apher Dial; 2014 Oct; 18(5):434-42. PubMed ID: 24251784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycated albumin may be a choice, but not an alternative marker of glycated hemoglobin for glycemic control assessment in diabetic patients undergoing maintenance hemodialysis.
    Chen FK; Sun XF; Zhang D; Cui SY; Chen XM; Wei RB; Lu JM; Li JJ; Liu WH; Zhang DL; Zhang ZM
    Chin Med J (Engl); 2013; 126(17):3295-300. PubMed ID: 24033952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of HbA
    Lee MY; Huang JC; Chen SC; Chiou HC; Wu PY
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.